Richard Lehman’s journal review—29 September 2014

NEJM 25 September 2014 Vol 371 1189  This week we start with mepolizumab. Before we know it, we encounter losmapimod. Enough is enough. I think the World Health Organization should convene an extraordinary meeting of the International Nonproprietary Names Committee with the sole purpose of Stopping Silly Names. Medical practitioners are serious people and they […]

Read More…

The BMJ Today: Death talk in India

How viable is a system of “verbal autopsy” to determine future health policy in a country where most deaths occur outside hospitals, are not attended by doctors, and are not medically certified? Meera Kay finds out more about India’s recently completed Million Deaths Study and the training of non-medical field workers to record written narratives, from […]

Read More…

Neal Maskrey: When paradigms shift

When paradigms shift it’s always disconcerting. Thomas Samuel Kuhn published The Structure of Scientific Revolutions in 1962 and it’s become a decisive text on the nature of science. He used the term “paradigm” to describe the belief system that underpins puzzle solving in science. Far from discovering any absolute “truth,” normal science progresses routinely within […]

Read More…

The BMJ Today: Beyond doing no harm, helping can get tough

Medicine can do great things, but at today’s thebmj.com things look rather bleak. Nine out of 10 people who are transferred to hospital with cardiac arrest don’t survive to discharge. Some argue that most of these ambulance transfers should not happen at all; others disagree. It’s not about the cost, as Americans have calculated the savings […]

Read More…

David Lock: Avastin and Lucentis—It’s time for NHS commissioners to act rationally by limiting the choices for wet AMD patients

The news that a Cochrane Review has concluded that Avastin (bevacizumab) is as safe as Lucentis (ranibizumab) to treat patients with wet age related macular degeneration (“wet AMD”), along with other studies that have shown the two drugs have broadly the same level of clinical effectiveness, comes as no surprise to those of us who have been […]

Read More…

The BMJ Today: Time to engage with politics and policy

No sooner had I finished reading my colleague’s blog about taking a global view of health, than I found myself reading Jocalyn Clark’s analysis, which questions where the efforts for solutions to global health issues should be focussed. She states her case clearly: good health is interlinked with the economy and the “medicalisation of global health […]

Read More…

Alex Horne: The expense of neglecting adolescent mental health

The chief medical officer, Dame Sally Davies, recently called for more support for mental health services in her annual report, which highlighted how mental illness led to the loss of 70 million working days last year—an increase of 24% since 2009. Of particular importance is the report’s call for improved support for young people with mental […]

Read More…